Sensitization of catastrophic cognition in cognitive-behavioral therapy for panic disorder.

Sensitization of catastrophic cognition in cognitive-behavioral therapy for panic disorder. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Sensitization of catastrophic cognition in cognitive-behavioral therapy for panic disorder. Abstract Text:

Yumiko Noda,Yumi Nakano,Kiyoe Lee,Sei Ogawa,Yoshihiro Kinoshita,Tadashi Funayama,Norio Watanabe,Junwen Chen,Yuka Noguchi,Miyako Kataoka,Masako Suzuki,Toshi A Furukawa,Yumiko Noda,Yumi Nakano,Kiyoe Lee,Sei Ogawa,Yoshihiro Kinoshita,Tadashi Funayama,Norio Watanabe,Junwen Chen,Yuka Noguchi,Miyako Kataoka,Masako Suzuki,Toshi A Furukawa,

BACKGROUND: Cognitive model of panic disorder have proposed that panic attacks result from the catastrophic misinterpretation of certain bodily sensations. Cognitive-Behavioral Therapy (CBT) for panic disorder aims to change these catastrophic cognitions. CBT intervention successfully caused reduction of catastrophic cognitions and symptomatic improvement in the majority of cases. However there are some patients who fail to modify their catastrophic cognitions or rather experience an increase in them during CBT treatment. It is clinically and theoretically important to understand about cognitive sensitization of panic disorder during CBT sessions. The purpose of the present study is 1) to clarify the baseline characteristics of panic patients who would experience sensitization of their catastrophic cognitions through the CBT treatment, and 2) to examine the course of symptomatic changes for them. METHODS: Of ninety-five outpatients with panic disorder started the group CBT program for treatment of panic disorder, seventy-nine completer were classified as "cognitively sensitized (CS)" or "cognitive responding (CR)" or "no-responder" according to the difference of the Agoraphobic Cognitions Questionnaire score across treatment. We compared the CS and CR patients in terms of their baseline clinical characteristics. Then we assessed the symptomatic and functional changes for both groups. RESULTS: At the start of the CBT program, despite of the same degree of panic disorder severity, CS scored significantly lower on ACQ score than CR. CS also showed significantly lower score on anticipatory anxiety compared to CR. At the end of treatment CS showed significant improvement in severity of panic disorder, although the degree of improvement was smaller than that for CR. Then CS would progressively reduce their agoraphobic fear and avoidance, and would improve their functional impairment up to three month of follow-up. CONCLUSION: Panic patients who would experience sensitization of their catastrophic cognitions through the CBT treatment could nonetheless gradually improve. They showed a relatively low level of catastrophic cognition and anticipatory anxiety before starting the CBT program. We might conclude that temporary sensitization of catastrophic cognition may be necessary before improvement especially among those with initially low catastrophic body sensation fears and that we need not be concerned too much with temporary increase in catastrophic cognition in the process of CBT for panic disorder.

Sensitization of catastrophic cognition in cognitive-behavioral therapy for panic disorder. Publishing Authors By Initials

Y Noda,Y Nakano,K Lee,S Ogawa,Y Kinoshita,T Funayama,N Watanabe,J Chen,Y Noguchi,M Kataoka,M Suzuki,TA Furukawa,Y Noda,Y Nakano,K Lee,S Ogawa,Y Kinoshita,T Funayama,N Watanabe,J Chen,Y Noguchi,M Kataoka,M Suzuki,TA Furukawa,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Sensitization of catastrophic cognition in cognitive-behavioral therapy for panic disorder. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: BMC psychiatry

VOLUME: 7

Page Numbers: 70

Journal Abbreviation:

ISSN: 1471-244X

DAY: 10

MONTH: 12

YEAR: 2007

Sensitization of catastrophic cognition in cognitive-behavioral therapy for panic disorder. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 100968559

Sensitization of catastrophic cognition in cognitive-behavioral therapy for panic disorder. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Sensitization of catastrophic cognition in cognitive-behavioral therapy for panic disorder. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Sensitization of catastrophic cognition in cognitive-behavioral therapy for panic disorder.

AFFILIATION: Department of Psychiatry and Cognitive-Behavioral Medicine, Nagoya City University Graduate School of Medical Sciences, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan. yumiko-n@mvh.biglobe.ne.jp

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: BMC Psychiatry

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Sensitization of catastrophic cognition in cognitive-behavioral therapy for panic disorder Related Publications

• Biogeochemical consequences of macrofauna burrow ventilationdagger.
• Clinical effects of undershirts coated with borage oil on children with atopic dermatitis: A double-blind, placebo-controlled clinical trial.
• Comparison of sleep parameters at titration and subsequent compliance between CPAP-pretreated and non-CPAP-pretreated patients with obstructive sleep apnea.
• E2F-6 suppresses growth-associated apoptosis of human hematopoietic progenitor cells by counteracting proapoptotic activity of E2F-1.
• Emotional distress and its correlates among parents of children with pervasive developmental disorders.
• Enhancement of in vitro and in vivo anti-tumor activity of anti-GD2 monoclonal antibody 220-51 against human neuroblastoma by granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor.
• Evaluation of diagnostic criteria for panic attack using item response theory: Findings from the National Comorbidity Survey in USA.
• Evaluation of optimal drug concentration in histoculture drug response assay in association with clinical efficacy for head and neck cancer.
• Feasibility of a membrane-aerated biofilm reactor to achieve single-stage autotrophic nitrogen removal based on Anammox.
• Functional roles of Otx2 transcription factor in postnatal mouse retinal development.
• Further observation of content uniformity of d-alpha-tocopheryl acetate as an oily drug in granules obtained by wet granulation with a high-shear mixer.
• Ictal electroencephalographic correlates of posttreatment neuropsychological changes in electroconvulsive therapy: a hypothesis-generation study.
• In vitro Evaluation of Dose-Response Curve for Paclitaxel in Breast Cancer.
• Independent associations of alexithymia and social support with depression in hemodialysis patients.
• Intra-arterial chemotherapy less intensive than RADPLAT with concurrent radiotherapy for resectable advanced head and neck squamous cell carcinoma: a prospective study.
• Mechanisms of neuronal death in synucleinopathy.
• Middle Turbinate Fenestration Method: A New Technique for the Treatment of Olfactory Disturbance due to Chronic Sinusitis.
• Molecular genetics of intraductal papillary-mucinous neoplasms of the pancreas.
• Nevoid basal cell carcinoma syndrome successfully treated with trichloroacetic acid and phenol peeling.
• Nuclear factor-kappaB activation in peripheral blood mononuclear cells in children with sepsis.
• Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease.
• Progesterone regulates cardiac repolarization through a nongenomic pathway: an in vitro patch-clamp and computational modeling study.
• Reliability and validity of the Japanese version of the Dysexecutive Questionnaire (DEX) in Alzheimer's disease: validation of a behavioral rating scale to assess dysexecutive symptoms in Japanese patients with Alzheimer's disease.
• Retinal blood oxygen saturation mapping by multispectral imaging and morphological angiography.
• Royal jelly and its unique fatty acid, 10-hydroxy-trans-2-decenoic acid, promote neurogenesis by neural stem/progenitor cells in vitro.
• Synthetic cinnamylphenol derivatives as cancer chemopreventive agents.
• The lysine 831 of vascular endothelial growth factor receptor 1 is a novel target of methylation by SMYD3.
• The new GRID Hamilton Rating Scale for Depression demonstrates excellent inter-rater reliability for inexperienced and experienced raters before and after training.
• Two dimensions of anosognosia in patients with Alzheimer's disease: Reliability and validity of the Japanese version of the Anosognosia Questionnaire for Dementia (AQ-D).
• Undershirts coated with borage oil alleviate the symptoms of atopic dermatitis in children.